Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,547,568
  • Shares Outstanding, K 1,282,014
  • Annual Sales, $ 33,537 M
  • Annual Income, $ 4,662 M
  • EBIT $ 8,114 M
  • EBITDA $ 10,975 M
  • 60-Month Beta 0.71
  • Price/Sales 3.86
  • Price/Cash Flow 13.02
  • Price/Book 2.65

Options Overview Details

View History
  • Implied Volatility 29.67% (+3.28%)
  • Historical Volatility 19.03%
  • IV Percentile 98%
  • IV Rank 56.43%
  • IV High 41.66% on 04/08/25
  • IV Low 14.14% on 12/09/25
  • Expected Move (DTE 5) 4.16 (4.18%)
  • Put/Call Vol Ratio 0.69
  • Today's Volume 42,076
  • Volume Avg (30-Day) 10,271
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 180,249
  • Open Int (30-Day) 166,436
  • Expected Range 95.33 to 103.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/26
See More
  • Average Estimate 1.33
  • Number of Estimates 11
  • High Estimate 1.34
  • Low Estimate 1.33
  • Prior Year 1.39
  • Growth Rate Est. (year over year) -4.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.68 +3.98%
on 01/20/26
105.50 -5.70%
on 02/04/26
+3.07 (+3.18%)
since 01/13/26
3-Month
95.14 +4.57%
on 11/14/25
106.33 -6.43%
on 11/26/25
+3.35 (+3.48%)
since 11/13/25
52-Week
79.55 +25.07%
on 04/09/25
106.33 -6.43%
on 11/26/25
+7.29 (+7.91%)
since 02/13/25

Most Recent Stories

More News
Medtronic receives FDA clearance for Stealth AXiSâ„¢ surgical system, first integrated planning, navigation and robotics platform for spine surgery

GALWAY, Ireland , Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth...

MDT : 99.49 (-1.38%)
Medtronic to announce financial results for its third quarter of fiscal year 2026

GALWAY, Ireland , Feb. 11, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17,...

MDT : 99.49 (-1.38%)
Medtronic advances its innovation strategy with intent to acquire CathWorks

GALWAY, Ireland , Feb. 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will exercise its option to acquire CathWorks, a privately held...

MDT : 99.49 (-1.38%)
Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?

Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

XLV : 157.67 (+1.07%)
$SPX : 6,836.17 (+0.05%)
MDT : 99.49 (-1.38%)
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances

GALWAY, Ireland , Feb. 2, 2026  /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and...

MDT : 99.49 (-1.38%)
Afferaâ„¢ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360â„¢ PFA catheter to treat paroxysmal atrial fibrillation

First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe

MDT : 99.49 (-1.38%)
What to Expect From Medtronic's Next Quarterly Earnings Report

Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit drop.

XLV : 157.67 (+1.07%)
$SPX : 6,836.17 (+0.05%)
MDT : 99.49 (-1.38%)
Medtronic Diabetes announces FDA clearance for MiniMed Goâ„¢ Smart MDI system featuring Instinct sensor made by Abbott

MiniMed Goâ„¢ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily injections...

MDT : 99.49 (-1.38%)
Study showed MiniMedâ„¢ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

GALWAY, Ireland , Jan. 7, 2026 /PRNewswire/ -- A new real-world retrospective analysis published in Diabetes Care  showed that users of the MiniMed™ 780G system achieved American Diabetes...

MDT : 99.49 (-1.38%)
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

GALWAY, Ireland , Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference...

MDT : 99.49 (-1.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 105.01
2nd Resistance Point 103.76
1st Resistance Point 101.62
Last Price 99.49
1st Support Level 98.24
2nd Support Level 96.99
3rd Support Level 94.85

See More

52-Week High 106.33
Last Price 99.49
Fibonacci 61.8% 96.10
Fibonacci 50% 92.94
Fibonacci 38.2% 89.78
52-Week Low 79.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar